» Articles » PMID: 27891077

Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?

Overview
Specialty Cell Biology
Date 2016 Nov 29
PMID 27891077
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Drug abuse and addiction cause widespread social and public health problems, and the neurobiology underlying drug actions and drug use and abuse is an area of intensive research. Drugs of abuse alter synaptic transmission, and these actions contribute to acute intoxication as well as the chronic effects of abused substances. Transmission at most mammalian synapses involves neurotransmitter activation of two receptor subtypes, ligand-gated ion channels that mediate fast synaptic responses and G protein-coupled receptors (GPCRs) that have slower neuromodulatory actions. The GPCRs represent a large proportion of neurotransmitter receptors involved in almost all facets of nervous system function. In addition, these receptors are targets for many pharmacotherapeutic agents. Drugs of abuse directly or indirectly affect neuromodulation mediated by GPCRs, with important consequences for intoxication, drug taking and responses to prolonged drug exposure, withdrawal and addiction. Among the GPCRs are several subtypes involved in presynaptic inhibition, most of which are coupled to the G class of G protein. There is increasing evidence that these presynaptic G-coupled GPCRs have important roles in the actions of drugs of abuse, as well as behaviors related to these drugs. This topic will be reviewed, with particular emphasis on receptors for three neurotransmitters, Dopamine (DA; D- and D-like receptors), Endocannabinoids (eCBs; CB1 receptors) and glutamate (group II metabotropic glutamate (mGlu) receptors). The focus is on recent evidence from laboratory animal models (and some evidence in humans) implicating these receptors in the acute and chronic effects of numerous abused drugs, as well as in the control of drug seeking and taking. The ability of drugs targeting these receptors to modify drug seeking behavior has raised the possibility of using compounds targeting these receptors for addiction pharmacotherapy. This topic is also discussed, with emphasis on development of mGlu positive allosteric modulators (PAMs).

Citing Articles

Alcohol consumption does not impact delta and kappa opioid receptor-mediated synaptic depression in dorsolateral striatum of adult male mice.

Munoz B, Atwood B Alcohol. 2024; 119:89-95.

PMID: 38857678 PMC: 11296933. DOI: 10.1016/j.alcohol.2024.06.002.


Differential regulation of G protein-coupled receptor-associated proteins in the caudate and the putamen of cynomolgus macaques following chronic ethanol drinking.

Neel A, Wang Y, Sun H, Liontis K, McCormack M, Mayer J J Neurochem. 2024; 168(9):2722-2735.

PMID: 38783749 PMC: 11449652. DOI: 10.1111/jnc.16134.


Consecutive treatments of methamphetamine promote the development of cardiac pathological symptoms in zebrafish.

Zhang J, Nguyen A, Jilani D, Torres R, Schmiess-Heine L, Le T PLoS One. 2023; 18(11):e0294322.

PMID: 37976248 PMC: 10655962. DOI: 10.1371/journal.pone.0294322.


G protein-coupled receptor modulation of striatal dopamine transmission: Implications for psychoactive drug effects.

Littlepage-Saunders M, Hochstein M, Chang D, Johnson K Br J Pharmacol. 2023; 181(22):4399-4413.

PMID: 37258878 PMC: 10687321. DOI: 10.1111/bph.16151.


SNAP25 differentially contributes to G-coupled receptor function at glutamatergic synapses in the nucleus accumbens.

Manz K, Zepeda J, Zurawski Z, Hamm H, Grueter B Front Cell Neurosci. 2023; 17:1165261.

PMID: 37206665 PMC: 10188356. DOI: 10.3389/fncel.2023.1165261.


References
1.
Dougalis A, Matthews G, Bishop M, Brischoux F, Kobayashi K, Ungless M . Functional properties of dopamine neurons and co-expression of vasoactive intestinal polypeptide in the dorsal raphe nucleus and ventro-lateral periaqueductal grey. Eur J Neurosci. 2012; 36(10):3322-3332. PMC: 4273537. DOI: 10.1111/j.1460-9568.2012.08255.x. View

2.
Latek D, Modzelewska A, Trzaskowski B, Palczewski K, Filipek S . G protein-coupled receptors--recent advances. Acta Biochim Pol. 2012; 59(4):515-29. PMC: 4322417. View

3.
Schwendt M, Reichel C, See R . Extinction-dependent alterations in corticostriatal mGluR2/3 and mGluR7 receptors following chronic methamphetamine self-administration in rats. PLoS One. 2012; 7(3):e34299. PMC: 3315516. DOI: 10.1371/journal.pone.0034299. View

4.
Karkhanis A, Beveridge T, Blough B, Jones S, Ferris M . The individual and combined effects of phenmetrazine and mgluR2/3 agonist LY379268 on the motivation to self-administer cocaine. Drug Alcohol Depend. 2016; 166:51-60. PMC: 5003316. DOI: 10.1016/j.drugalcdep.2016.06.020. View

5.
Freedland C, Sharpe A, SAMSON H, Porrino L . Effects of SR141716A on ethanol and sucrose self-administration. Alcohol Clin Exp Res. 2001; 25(2):277-82. View